CRF Receptors in Anxiety and Depression: A New Selective CRF1 Agonist Tool Called Cortagine
A novel selective CRF1 agonist (cortagine) was developed to dissect CRF receptor roles, confirming CRF1 drives anxiety while CRF2 mediates stress recovery — enabling more precise stress receptor pharmacology.
Quick Facts
What This Study Found
The novel selective CRF1 agonist cortagine enabled clear dissection of CRF receptor roles: CRF1 activation drives anxiety/depression-like behavior while CRF2 activation promotes stress coping — precise tools for receptor-specific psychiatric drug development.
Key Numbers
How They Did This
review study on neuropeptides, anxiety-mood.
Why This Research Matters
Relevant for neuropeptides, anxiety-mood.
The Bigger Picture
Advances peptide/biomarker research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding The novel selective CRF1 agonist cortagine enabled clear dissection of CRF receptor roles: CRF1 activation drives anxiety/depression-like behavior whi
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2005.
- Original Title:
- The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
- Published In:
- Neuroscience and biobehavioral reviews, 29(8), 1323-33 (2005)
- Database ID:
- RPEP-01092
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
CRF Receptors in Anxiety and Depression: A New Selective CRF1 Agonist Tool Called Cortagine
What was found?
A novel selective CRF1 agonist (cortagine) was developed to dissect CRF receptor roles, confirming CRF1 drives anxiety while CRF2 mediates stress recovery — enabling more precise stress receptor pharmacology.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01092APA
Todorovic, Cedomir; Jahn, Olaf; Tezval, Hossein; Hippel, Cathrin; Spiess, Joachim. (2005). The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.. Neuroscience and biobehavioral reviews, 29(8), 1323-33.
MLA
Todorovic, Cedomir, et al. "The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.." Neuroscience and biobehavioral reviews, 2005.
RethinkPeptides
RethinkPeptides Research Database. "The role of CRF receptors in anxiety and depression: implica..." RPEP-01092. Retrieved from https://rethinkpeptides.com/research/todorovic-2005-the-role-of-crf
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.